Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.641 USD | -7.25% | -7.49% | +64.36% |
Apr. 18 | Renalytix chief business officer to become president | AN |
Apr. 18 | Renalytix Names Chief Business Officer as President | MT |
Financials (USD)
Sales 2024 * | 4M | Sales 2025 * | 18M | Capitalization | 51.11M |
---|---|---|---|---|---|
Net income 2024 * | -35M | Net income 2025 * | -26M | EV / Sales 2024 * | 12.8 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.84 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.42% |
Latest transcript on Renalytix Plc
1 day | -7.25% | ||
1 week | -7.49% | ||
Current month | -7.49% | ||
1 month | -19.88% | ||
3 months | +133.09% | ||
6 months | -39.53% | ||
Current year | +64.36% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 18-03-14 |
James Sterling
DFI | Director of Finance/CFO | 54 | 18-03-14 |
Howard Doran
PSD | President | 63 | 23-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 21-08-29 |
Chairman | 72 | 18-03-14 | |
James McCullough
FOU | Founder | 56 | 18-03-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.641 | -7.25% | 214,322 |
24-05-07 | 0.6911 | +0.17% | 237,624 |
24-05-06 | 0.6899 | -1.46% | 161,878 |
24-05-03 | 0.7001 | -7.76% | 217,898 |
24-05-02 | 0.759 | -3.92% | 532,732 |
Delayed Quote Nasdaq, May 08, 2024 at 04:30 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.87% | 18.81B | |
-42.09% | 2.93B | |
+23.15% | 1.95B | |
+3.08% | 1.79B | |
+28.27% | 1.25B | |
-11.16% | 1.07B | |
-17.21% | 948M | |
+0.07% | 770M | |
-23.17% | 648M |
- Stock Market
- Equities
- RENX Stock
- RNLX Stock